Regulating nanomedicine: new nano tools offer great promise for the future-if regulators can solve the difficulties that hold development back

In 1979, a Hebrew University biochemist named Yechezkel Barenholz teamed with Alberto Gabizon, a newly minted Ph.D. from the Weizmann Institute of Science, to find a better way to give chemotherapeutic doxorubicin to patients with cancer.